Ignite Creation Date:
2025-12-24 @ 5:41 PM
Ignite Modification Date:
2025-12-27 @ 1:49 PM
Study NCT ID:
NCT05496868
Status:
COMPLETED
Last Update Posted:
2025-10-27
First Post:
2022-08-04
Is NOT Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Add-on Reparixin in Adult Patients With ARDS
Sponsor:
Dompé Farmaceutici S.p.A
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
2022-12-06
Start Date Type:
ACTUAL
Primary Completion Date:
2025-03-18
Primary Completion Date Type:
ACTUAL
Completion Date:
2025-04-18
Completion Date Type:
ACTUAL
First Submit Date:
2022-08-04
First Submit QC Date:
None
Study First Post Date:
2022-08-11
Study First Post Date Type:
ACTUAL
Results First Submit Date:
None
Results First Submit QC Date:
None
Results First Post Date:
None
Results First Post Date Type:
None
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2025-10-23
Last Update Post Date:
2025-10-27
Last Update Post Date Type:
ESTIMATED